DBIA
TEVA icon

Dumont & Blake Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,422
Closed -$527K – 194
2017
Q1 		$527K Buy
16,422
+325
+2% +$11.1K 0.24% 121
2016
Q4 		$584K Sell
16,097
-4,712
-23% -$188K 0.27% 116
2016
Q3 		$957K Sell
20,809
-110
-0.5% -$5.74K 0.47% 77
2016
Q2 		$1.05M Sell
20,919
-675
-3% -$35.9K 0.53% 65
2016
Q1 		$1.16M Sell
21,594
-450
-2% -$26.4K 0.6% 54
2015
Q4 		$1.45M Buy
22,044
+225
+1% +$13.9K 0.74% 40
2015
Q3 		$1.23M Sell
21,819
-4,878
-18% -$316K 0.67% 52
2015
Q2 		$1.58M Hold
26,697
– – 0.77% 39
2015
Q1 		$1.66M Buy
26,697
+45
+0.2% +$2.62K 0.81% 41
2014
Q4 		$1.53M Hold
26,652
– – 0.76% 46
2014
Q3 		$1.43M Sell
26,652
-250
-0.9% -$13.2K 0.74% 46
2014
Q2 		$1.41M Sell
26,902
-250
-0.9% -$12.8K 0.71% 47
2014
Q1 		$1.44M Sell
27,152
-748
-3% -$34.6K 0.75% 46
2013
Q4 		$1.12M Sell
27,900
-2,285
-8% -$90K 0.58% 68
2013
Q3 		$1.14M Buy
30,185
+200
+0.7% +$7.8K 0.54% 73
2013
Q2 		$1.18M Buy
+29,985
New +$1.17M 0.71% 55

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dumont & Blake Investment Advisors's TEVA Position: Q2 2017 in Review

Dumont & Blake Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 16,422 shares — an estimated $527K sold.

Dumont & Blake Investment Advisors first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $1.66M in Q1 2015. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Dumont & Blake Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Dumont & Blake Investment Advisors sold 16,422 Teva Pharmaceuticals shares in Q2 2017, an estimated $527K.
  • Dumont & Blake Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Dumont & Blake Investment Advisors's Teva Pharmaceuticals position peaked at $1.66M in Q1 2015.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Dumont & Blake Investment Advisors's 13F filing for Q2 2017, filed 28 Jul 2017.